Rayno Life Sciences Tools and Diagnostics: Alere, Cepheid, Quidel and Response Genetics
All of these stocks are already on our focus list but lately have shown signs of strength.
Cepheid (CPHD) has been added as a new long term buy at $31.5.
Quidel has two news items and recent strength:
Jack Schuler has added positions to 15.3% and the Flu season has an early start.
Response Genetics (RGDX) has made a big move above base of $1.10: